COVID-19 vaccination for people with severe mental illness: why, what, and how?
Lancet Psychiatry
; 8(5): 444-450, 2021 05.
Article
in English
| MEDLINE | ID: covidwho-1537216
ABSTRACT
Psychiatric disorders, and especially severe mental illness, are associated with an increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19-related morbidity and mortality. People with severe mental illness should therefore be prioritised in vaccine allocation strategies. Here, we discuss the risk for worse COVID-19 outcomes in this vulnerable group, the effect of severe mental illness and psychotropic medications on vaccination response, the attitudes of people with severe mental illness towards vaccination, and, the potential barriers to, and possible solutions for, an efficient vaccination programme in this population.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immunization Programs
/
COVID-19
/
Mental Disorders
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Lancet Psychiatry
Year:
2021
Document Type:
Article
Affiliation country:
S2215-0366(20)30564-2
Similar
MEDLINE
...
LILACS
LIS